Organization
Seattle Genetics, Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Seattle Genetics, Inc.
... Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and ...
... to the investment community. Today we are offering reports on RARE, REGN, SGEN, and SGMO which can be accessed for free by signing up tohttp://www.wallstequities.com/registration. ...
... New York (January 8, 2018, 5:32 PM EST) -- Cancer-drug maker Seattle Genetics Inc. on Friday asked a Washington federal court for a third time ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) highlighted today the progress of its pipeline of antibody-drug conjugates ...
... Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the U.S. Food and Drug Administration (FDA) ...
... the first stage of a comprehensive technology roadmap." Purdue Pharma, Sanofi, and Seattle Genetics have committed sponsorship to support development of the technology. In addition, ...
... Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief ...
... others; but it also includes smaller niche companies such as Genmab and Seattle Genetics. In addition, it includes leading biopharmaceutical firms such as Amgen and ...
... ATLANTA - Seattle Genetics, Inc. (NASDAQ: SGEN) and Bristol-Myers Squibb Company (NYSE: BMY) today highlighted updated interim ...
... Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ECHELON-1 clinical ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) today highlighted updated results from the phase 3 ALCANZA clinical ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) today announced updated data from an ongoing phase 1 clinical ...
... Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that the company will webcast an investor and ...
... the current clinical pipeline are being developed using the technologies provided by Seattle Genetics and ImmunoGen; however, several small sized companies have emerged in last ...
... Inc., Bristol-Myers Squibb, GlaxoSmithKline Plc, F. Hoffmann-La Roche AG, Eli Lilly, Seattle Genetics, Inc., Spectrum Pharmaceuticals, Inc., Celgene Corporation are some notable companies vying for ...
... protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing Seattle Genetics' proprietary technology. The ADC employs a linker system that is designed ...
... Inc. (NYSE:GRUB), Patterson Companies, Inc. (NASDAQ:PDCO), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), and Seattle Genetics, Inc. (NASDAQ:SGEN) including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified ...
... Seattle Genetics, Inc. = 20 percent) were: anemia, peripheral sensory neuropathy, nausea, diarrhea, fatigue ...
... Seattle Genetics, Inc. (NASDAQ: SGEN) and Astellas Pharma Inc. (TSE: 4503, President and CEO: Yoshihiko ...
... in Phase III ALCYONE study of daratumumab in front line multiple myeloma Seattle Genetics exercised its option to co-develop tisotumab vedotin with Genmab "This past ...
... for the first time during the Plenary Scientific Session in partnership with Seattle Genetics. Topline data from ECHELON-1, which was reported in June 2017, demonstrated ...
... If you want a Stock Review on KURA, PGNX, REGN, or SGEN then come over tohttp://dailystocktracker.com/register/and sign up for your free customized report. For ...
... for the first time during the Plenary Scientific Session in partnership with Seattle Genetics. Topline data from ECHELON-1, which was reported in June 2017, demonstrated ...
... Seattle Genetics, Inc. (Nasdaq: SGEN) today announced that 18 abstracts featuring data from the broad ...
Want to see the full history on Seattle Genetics, Inc.? Upgrade to RelSci Pro now!
Start My Free Trial